Albemarle Corp. (ALB) Stock Price Today
Aura AI Summary
Key Stats
- $15.29BMarket Cap
- -Volume
- Basic MaterialsSector
- $215.6252W High
- $72.5852W Low
- -Typical Hold Time
- $17.77BEnterprise Value
- 1.27%Div Yield
- -Trading Activity
Track Albemarle Corp. (ALB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Albemarle Corp. has traded between a low of $72.58 and a high of $215.62, highlighting its annual price range. Buy and sell Albemarle Corp. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Albemarle Corp.
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Most Recent News
Novartis shares plunge 12.5% after two Phase 3 drug trials fail primary goals
Novartis shares dropped over 12.5% after its Phase 3 HARBOR trial for del-desiran and Phase 3 HORIZON trial for pelacarsen both failed to meet primary endpoints. These failures mean the drugs did not show significant benefits over placebo for their t...

Levi & Korsinsky probes lululemon over tariff refund disclosures after earnings and guidance cuts.
Levi & Korsinsky is investigating lululemon athletica for potentially misleading disclosures about a $134.5 million federal tariff refund included in its recent quarterly earnings. The refund boosted earnings per share by $0.86 and operating margins,...

Structure Therapeutics shows strong obesity drug results, remains a strong buy with $1.3B cash runway.
Structure Therapeutics reported promising 72-week data for its oral obesity drug aleniglipron, showing 16.2% weight loss with low adverse event discontinuations and no liver injury. The company also advanced ACCG-2671, an oral amylin agonist with hum...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.